LCTX.TALCTX.TATLV
Loading
R&D Expense Growth Recovery in ProgressRecovering
Percentile Rank62
3Y CAGR-15.4%
5Y CAGR-27.8%
Year-over-Year Change
Year-over-year research & development expense growth
3Y CAGR
-15.4%/yr
vs +15.3%/yr prior
5Y CAGR
-27.8%/yr
Recent acceleration
Acceleration
-30.8pp
Decelerating
Percentile
P62
Within normal range
vs 5Y Ago
0.2x
Contraction
Streak
2 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q3 2025 | 5.31% |
| Q2 2025 | -0.26% |
| Q1 2025 | -9.03% |
| Q4 2024 | 7.95% |
| Q3 2024 | 10.56% |
| Q2 2024 | -4.72% |
| Q1 2024 | -22.94% |
| Q4 2023 | 4.41% |
| Q3 2023 | -3.41% |
| Q2 2023 | -7.46% |
| Q1 2023 | 1.97% |
| Q4 2022 | 14.25% |
| Q3 2022 | 8.78% |
| Q2 2022 | 10.51% |
| Q1 2022 | -87.94% |
| Q4 2021 | 781.47% |
| Q3 2021 | -4.09% |
| Q2 2021 | -13.64% |
| Q1 2021 | 30.19% |
| Q4 2020 | -26.89% |
| Q3 2020 | 27.13% |
| Q2 2020 | -15.99% |
| Q1 2020 | -4.22% |
| Q4 2019 | -18.28% |
| Q3 2019 | -18.51% |
| Q2 2019 | 5.52% |
| Q1 2019 | 31.24% |
| Q4 2018 | -22.57% |
| Q3 2018 | -23.21% |
| Q2 2018 | 7.13% |
| Q1 2018 | 26.36% |
| Q4 2017 | -28.42% |
| Q3 2017 | 4.64% |
| Q2 2017 | -3.43% |
| Q1 2017 | -7.40% |
| Q4 2016 | 9.20% |
| Q3 2016 | -28.15% |
| Q2 2016 | -34.92% |
| Q1 2016 | 7.40% |
| Q4 2015 | 11.85% |